Annovis Bio Inc (ANVS) FinancialsANVSAnnovis Bio Inc

Evaluating the bottom line, Annovis Bio Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -703.68%, provide a clear picture of how effectively ANVS converts its operational activities into shareholder value.

In the context of the broader market, ANVS competes directly with industry leaders such as HOWL and ATNM. With a market capitalization of $51.64M, it holds a significant position in the sector. When comparing efficiency, ANVS's gross margin of N/A stands against HOWL's 100.00% and ATNM's 100.00%. Such benchmarking helps identify whether Annovis Bio Inc is trading at a premium or discount relative to its financial performance.

The company has faced significant losses, with net income projected to be negative for the upcoming quarters, indicating ongoing financial challenges. However, the current ratio remains strong at 3.47, suggesting good short-term liquidity.